Also: mRNA, once lauded as a scientific marvel, is now a government targetJune 2, 2025Check out STAT+Sponsored By Photo illustration: Christine Kao/STAT; Photos: Alex Brandon/AP STAT+ | The shrewd startup founder who led DOGE's cost-cutting at HHS Brad Smith exhibited the same traits at DOGE as he did running his startups Aspire Health and CareBridge, including intensity and ambition. By Tara Bannow FDA commissioner evades questions on Covid shot, calls CDC panel a 'kangaroo court' The commissioner said data on shots in healthy children and pregnant people are mixed, and belittled the Advisory Committee for Immunization Practices. By Lizzy Lawrence STAT+ | FDA plans to begin rolling out AI tool agency-wide on Tuesday Commissioner Marty Makary has hailed the potential of the AI at the FDA, but employees told STAT its capabilities are being over-inflated. By Brittany Trang Stephen Maturen/Getty Images STAT+ | UnitedHealth conducting 'comprehensive review' of Medicare practices that are facing federal scrutiny, new CEO says Stephen Hemsley, UnitedHealth's new CEO, tells investors the company is reevaluating how it handles coding, managed care, and pharmacy services. By Tara Bannow STAT+ | Vera Therapeutics reports positive results from trial of kidney disease drug Company plans to file for FDA approval of the drug, called atacicept, but an Otsuka therapy may be a competitive threat. By Adam Feuerstein STAT+ | Sanofi to buy Blueprint Medicines in deal worth more than $9 billion The deal, which includes Blueprint's approved Ayvakit and a number of experimental drugs, will expand Sanofi's immunology pipeline. By Andrew Joseph BRENDAN SMIALOWSKI/AFP via Getty Images STAT+ | mRNA, once lauded as a scientific marvel, is now a government target The sharp turnaround on mRNA vaccines shows an unprecedented rise of anti-vaccine activists to power and an attack on accepted science. By Lizzy Lawrence and Isabella Cueto More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2025, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments